Commercialization
UB Technology Incubator Welcomes New Companies
Construction on Sweet Home Road isn't the only thing being talked about these days at the University at Buffalo Technology Incubator at Baird Research Park. The facility, located on Sweet Home, has welcomed four new companies into its program. Newton LED, an innovative signage company, and Oncology Research Therapeutics, Inc., life-sciences company that specializes in offering cancer-based diagnostics to physicians, joined 23 other associate companies in calling the Incubator "home". Additionally, BioHammer and VertaSource are taking advantage of the Incubatorrsquos resources as affiliates of the program.
Research
NYSTAR, Reichert Fund Work to Develop Microfluidic Detector
Researchers at the University at Buffalo have developed a microfluidic device that rapidly tests live cells for responses to any stimulus by using electrical resistance to measure changes in cell volume. The device can measure the volume of organelles, vesicles and any other insulating objects such as the latex beads used in various biochemical assays. The chip has numerous potential applications, including the detection of drug/cell interactions, bacterial sensitivity to antibiotics and cancer cell susceptibility to chemotherapeutic agents.
Events
UNYTECH Holds 4th Annual Venture Forum
Eleven colleges and universities throughout upstate New York have joined together to host UNYTECH06, the fourth annual venture forum. The event which connects university-based start-up companies with potential investors that can help grow their business will be held on Tuesday, Sept. 19 and Wednesday, Sept. 20, 2006 in Rochester, NY.
Events
STOR Attends Biotechnology Conference
Biotechnology Industry Organization's annual conference, BIO2006, was one of the world's largest gatherings of biotechnology leaders in the world, attracting approximately 18,000 life sciences professionals, and UB STOR was there. STOR partnered with the Research Foundation of the State University of New York (SUNY) and the Buffalo-Niagara region to showcase the Universityrsquos research and innovative discoveries in the field of biotechnology.
Events
STOR Sponsors National Venture Fund Conference
The University at Buffalo Office of Science, Technology Transfer and Economic Outreach is a proud sponsor of the 13th Annual Conference of the National Association of Seed and Venture Funds (NASVF), a premier network of private, public and nonprofit organizations dedicated to growing their local economies by investing and facilitating investment in local entrepreneurs.
Commercialization
Out of the Lab and into the Marketplace
With the opening of UB's New York State Center of Excellence in Bioinformatics and Life Sciences on the Buffalo Niagara Medical Campus, UB has created a flashpoint for innovation and research in downtown Buffalo. But it is the business-support services UB provides its researchers and their scientific breakthroughs through the Office of Science, Technology Transfer and Economic Outreach (STOR) that will create the start-up businesses that establish the city as a center for the biotechnology and life sciences industries, according to Robert Genco, vice provost and director of STOR.
Commercialization
Team Developing R&D Software Wins Panasci TEC Competition
Providing products and services to biotechnology firms was the common denominator for the two teams that won more than $60,000 in cash and services in the University at Buffalo's annual Henry A. Panasci Jr. Technology Entrepreneurship Competition (Panasci TEC). Panasci TEC awards seed money and business services to the teams that present the best plan for launch of a viable new business.
Commercialization
New York Times: UB's Center for Excellence in Bioinformatics and Life Sciences Spurs Buffalo Biotech Industry
An article in the July 9, 2006 Sunday edition of the New York Times describes how UB's New York State Center of Excellence in Bioinformatics and Life Sciences is helping to create a new biotech industry in Buffalo. Featured in the article are Bruce A. Holm, executive director of the Center of Excellence and UB senior vice provost; Marnie LaVigne, the center's director of business development; and Steven Gill, associate professor of oral biology, who was recruited to the center from The Institute for Genomic Research.
Director's Message
Recent Successes and Managing Expectations
The UB Office of Science, Technology Transfer and Economic Outreach (STOR) has had several recent successes. Three UB technologies have received funding from the New York State Office of Science, Technology and Academic Research to develop products. These include Buffalo BioBlower Technologies, a UB start-up which is developing a device that can eradicate spores of virulent organisms such as B. anthrax in the air stream; Reichert, a local company, which is developing a microfluidic UB technology developed by Dr. Fred Sachs, which tests live cells for responses to stimulus by using electrical resistance to measure changes in cell volume; and Kinex, a UB start-up company that has licensed a series of drugs with the promise for treating cancer.
Research
Agent Protects Parkinson's Neurons from Rotenone Toxicity
Researchers at the University at Buffalo affiliated with the New York State Center of Excellence in Bioinformatics and Life Sciences have identified a novel agent that can protect neurons involved in Parkinson's disease from being destroyed by the pesticide rotenone.
Events
UB's Center of Excellence and Roswell Park Cancer Institute Center for Genetics and Pharmacology Celebrate Grand Opening
Creation of a life-sciences industry and economy for Buffalo Niagara took an historic step forward today with the grand opening of the University at Buffalo's New York State Center of Excellence in Bioinformatics and Life Sciences and the Roswell Park Cancer Institute (RPCI) Center for Genetics and Pharmacology.
Licensing
High Reversible Hydrogen Storage Capacity with Ultra-Fast Kinetics
This set of inventions describes novel matter (a combination of Lithium Oxide (Li2O)/ Lithium Nitride (Li3N)) and the procedure to employ the same to store (and release) hydrogen. An improved version of the same with LiNH2 pre-added is also presented and described. The objective of these technologies is to capture and use hydrogen as an energy source in fuel cells. The current focus of this technology is on fuel cells for vehicles although there is the intention and potential to adapt and re-engineer this to suit other applications (energy generation, industrial uses, etc).
Research
Magnetic Field Acts as "Remote Control" to Deliver Nanomedicine
A nanoparticle-based drug delivery concept in which an applied magnetic field directs the accumulation in tumor cells of custom-designed, drug-filled nanocarriers has been demonstrated by University at Buffalo researchers.
Licensing
Marine-Derived Pharmaceuticals: A Synthetic Method Enabling thier Development
Marine-derived bioactive compounds hold great promise as therapeutics in the treatment of human disease. One particular family of marine-derived diterpene compounds has demonstrated anti-cancer, anti-tubercular and anti-inflammatory activities. However, the complete evaluation of such compounds and the development of new medications derived from them have been restricted by limited supplies, low yields and inefficient methods for synthesis. Using a patented chiral catalyst, a method has been developed which not only allows for ready and practical access to sufficient quantities of these naturally occurring compounds but also enables the development of novel analogs that can be manipulated for specific pharmaceutical properties. Further, this method appears to be amenable to economic, industrial-scale synthesis, making it an ideal choice for pharmaceutical companies looking to develop new anti-cancer, anti-tubercular or anti-inflammatory agents.
Licensing
Organ Transplant Diagnostic Screen for Chronic Tissue Rejection
At the end of 2003 there were almost 160,000 people living in the United States with transplanted organs. There are an additional 25,000 organ transplants each year in the U.S., with a growing number still on the waiting list to receive an organ. In the six months following a transplant, a patient undergoes at least four biopsies, with subsequent biopsies at regular intervals for the remainder of their lives. These diagnostic procedures are designed for detection of life-threatening organ rejection. However, this microscopic diagnosis is imperfect in that it relies on non-specific changes in the organ, therefore the diagnosis is subjective and not definitive. Based on the recent discovery of tertiary lymphoid organs in tissue undergoing rejection, a less invasive diagnostic test has been developed to more objectively confirm transplants undergoing chronic rejection.
Research
UB Scientist Publishes First Human Microbiome Analysis
Researchers have completed the first analysis of the genes of a community of human microbes, an accomplishment that has far-reaching implications for clinical diagnosis and treatment of many human diseases.
Technology Transfer
UB Faculty Inventors Named on Patents
Eleven University at Buffalo faculty members were named on eight patents issued to The Research Foundation of State University of New York in 2005. Two of these patented technologies have already been licensed to companies that will bring new products to the market.
Licensing
Method for the Preparation of III-V Semiconductor Nanocrystals in a Non-coordinating Solvent by in-situ Surfactant Generation
UB Technology Available for Licensing: Method for the Preparation of III-V Semiconductor Nanocrystals in a Non-coordinating Solvent by in-situ Surfactant Generation
Licensing
Sample Transport Medium and Storage Kit For Bacterial Culture of Diagnostic Specimens
UB Technology Available for Licensing: Sample Transport Medium and Storage Kit For Bacterial Culture of Diagnostic Specimens
Licensing
LLINAP- For Targeted Delivery of Cancer Vaccine Antigen
UB Technology Available for Licensing: LINAP - for targeted delivery of cancer vaccine antigens
Commercialization
AMBP Tech Graduates from the UB Technology Incubator
AMBP Tech Corporation graduated this past fall from the UB Technology Incubator, located in Baird Research Park in Amherst, NY.
Commercialization
AMS Releases Latest Course Evaluation Software
Academic Management Systems (AMS), a software-development company located in the University at Buffalo Technology Incubator, has released CourseEval3, a Web-based evaluation tool. This new version of its well-established software provides colleges and universities with the ability to set up a wide variety of course, faculty and other assessment activities online.
Events
InfoTech Niagara BETAs
STOR is proud to announce that the UB Technology Incubator has been nominated for an InfoTech Niagara Buffalo/Niagara Emerging Technology Award (BETA).
Director's Message
Looking Forward
At the beginning of the new year, we often take time to reflect on the past and also to look to the future like the Roman God, Janus, who was not only able to see in the past, but also could look into the future. We've looked to the past and summarized the activities of the UB Office of Science, Technology Transfer and Economic Outreach (STOR) since its inception in 2002, and find the following. There were 302 disclosures, up from 45 per year in 2002 to approximately 90 per year in 2005. Approximately 74% of these disclosures resulted in patent applications, many provisional. From these 302 disclosures, 40 licenses or options have been secured, and 20 start-ups have spun out of the University. All of these figures are increasing over the pre-STOR days before 2002. We feel that progress has been made and we are headed in the right direction.
Research
Pharmacy School, Pfizer Create Strategic Alliance
The University at Buffalo's School of Pharmacy and Pharmaceutical Sciences today announced a strategic alliance with Pfizer, Inc., that will provide up to $7.5 million to develop at UB a Center of Excellence in Pharmacokinetics and Pharmacodynamics and to support training and research in pharmacokinetics and pharmacodynamics.
Research
Chemical Sensors to Sniff Out Diseases in Human Breath
How do you create a sensor that can "sniff" out diseases based on the highly complex odors that come out of our mouths? You base it on the real thing, according to University at Buffalo researchers. They are developing a rugged, inexpensive Breathalyzer-type device that, just like the nose of a human -- or other mammal -- will contain thousands of chemical sensors "trained" to recognize complex chemical patterns, some of which are known biomarkers for certain diseases.
Research
Fingerprint Advances Will Fight Cyber
Forgot your password? No problem. Biometrics researchers at the University at Buffalo have made important advances that bring closer the day when we can access devices and Web sites with nothing more than the touch of a fingertip.
Research
UB, RPCI Win Cancer Nanotechnology Research Grants
The University at Buffalo and Roswell Park Cancer Institute are two out of only 12 institutions in the nation that the National Cancer Institute has chosen to pioneer a new generation of cancer diagnostics and treatments based on nanotechnology.
Research
Message from the Director
We are pleased to present the first edition of our STOR e-newsletter. This format should allow you to pursue information and stories that interest you in an efficient fashion.
Commercialization
Slaughter Announces $3 Million to Launch UB Spin-Off
A $3 million Department of Defense appropriation to Buffalo BioBlower Technologies LLC, a spin-off of the University at Buffalo, announced by Rep. Louise M. Slaughter, will allow the new company to begin commercializing its powerful air sterilization device.
WNY Technology & Biomedical Informatics Forum
The County of Niagara, InfoTech Niagara and Bufflink have announced the date for the fifth annual WNY Technology & Biomedical Informatics Forum. The all day event will take place Monday, October 31, 2005 at the Niagara Falls Conference Center from 9:00 a.m. ndash 5:00 p.m.
Statewide Conference on the Business Side of Patents to be Held in NYC
The New York State Science and Technology Law Center at Syracuse University and its partners, University at Buffalo and City University at New York (CUNY), will be hosting the second statewide ldquoLab to Marketrdquo conference on technology commercialization. The two-day conference titled ldquoThe Business Side of Patentsrdquo will be held at the CUNY Graduate Center in New York City on October 27 and 28, 2005.
Commercialization
Commercializing Discoveries Aim of New Collaboration
STOR and First Wave Technologies, Inc., a technology-development company, have announced their proactive collaborative effort to expand the commercialization of early-stage university technologies utilizing private-sector resources.
Technology Transfer
STOR Welcomes Fowler and Dee
STOR is pleased to welcome Michael L. Fowler, Ph.D., bioinformatics and health sciences commercialization manager, and Timothy P. Dee, D.C., associate commercialization manager.
Commercialization
UB Biotech Company Develops Molecule to Attack Fast-growing Cancer
A University at Buffalo drug development company, Kinex Pharmaceuticals, has produced a molecule that company officials say attacks fast-growing cancer cells. Developers believe this molecule can also help with the treatment of osteoporosis, hearing loss, ophthalmic disease and myocardial ischemia.
Funding
The Search is on for Participants in the UB Panasci Technology Entrepreneur Competition
Recent University at Buffalo alumni and current UB students with innovative ideas in the technology, life sciences and engineering industries are being sought to participate in the third annual Henry A. Panasci Jr. Technology Entrepreneurship Competition.
Funding
Companies Pitch to Investors at UNYTECH05
The third annual UNYTECH05 - Universities of Upstate New York Venture Forum was held in Buffalo, New York, on September 21-22, 2005. Start-up technology companies, grown from discoveries and innovations within the college and university systems, presented their business model and investment pitch to group of close to 200 venture capitalist, private investors, and service providers. Companies that presented at the previous two forums raised over $14 million in private funding and government grants.
Commercialization
UB Recognizes Faculty Scholars, Inventors and Entrepreneurs at Reception
The University at Buffalo today recognized 42 faculty members and researchers at a Scholars, Inventors and Entrepreneurs Reception in the Center for Tomorrow on the UB North (Amherst) Campus. The annual reception honors the research and commercialization achievements of faculty members in the following categories: Licenses to Industrial Partners, U.S. Patents, Center for Advanced Biomedical and Bioengineering Technology (CAT), and Exceptional Scholars Awards. Additionally, the university honored nine companies that joined the UB Technology Incubator program in 2004
Research
UB's New Dell Cluster Nearly Doubles Center's Capacity
n response to the soaring demand for computational power by the hundreds of researchers who depend on it, the University at Buffalo has expanded the computing capacity of the Center for Computational Research in its New York State Center of Excellence in Bioinformatics and Life Sciences with the installation of a new Dell high-performance computing cluster. The cluster, with 1,668 processors, nearly doubles the Center of Excellence's computing capacity. If this cluster was listed on the current top 500 list of the world's fastest supercomputers, (http://www.top500.org), it would be among the 40 fastest individual machines.
Research
Center of Excellence Making Progress Toward Improving Health Care, Spurring Economic Development
The new building on the Buffalo Niagara Medical Campus is nearing completion. The scientific agenda has been solidified, corporate partners identified and a formal organizational and governance structure adopted. Barely four years after Gov. George Pataki announced an ambitious proposal to create jobs and jump-start the New York State economy through the creation of high-technology "centers of excellence," UB's New York State Center of Excellence in Bioinformatics and Life Sciences is well on its way toward fulfilling its dual mission of improving health care while facilitating economic development in Upstate New York.
Licensing
UB Licenses Sleep Apnea Diagnostic Technology
The University of Buffalo has signed an agreement with Sleep Solutions, Inc., the medical device and health-care services company providing direct-to-patient testing services, to commercialize and distribute an innovative diagnostic testing technology for obstructive sleep apnea (OSA) and Cheyne-Stokes respiration (CSR)
Commercialization
Creators of Pricing Tool for Online Auctions Win UB Technology Entrepreneur Competition
Three MBA students from the University at Buffalo School of Management comprised the team that won more than $30,000 in cash and prizes at UB's annual Henry A. Panasci Jr. Technology Entrepreneurship Competition (Panasci TEC) for their new venture, AuctionCruncher.com.
